We found that RSL3 increased the mRNA and protein levels of Parkin in a concentration‐ and time‐dependent manner in HCT116 and MDA‐MB‐231 cancer cells (Figure S2K,L, Supporting Information). The gene discussed is PRKN; the disease is cancer.